Brian Byeoung Kim
Algemeen Directeur bij BIOHAUS Co., Ltd.
Actieve functies van Brian Byeoung Kim
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
BIOHAUS Co., Ltd.
 BIOHAUS Co., Ltd. Pharmaceuticals: MajorHealth Technology BIOHAUS Co., Ltd. engages in the development and manufacture of fucntional health and synthetic biology products. Its products include bio plastics and pulps and natural antibacterial wet tissues. The company was founded in August 2012 and is headquartered in Seongnam, South Korea. | Algemeen Directeur | 01-01-2012 | - |
| Voorzitter | 01-01-2012 | - |
Loopbaan van Brian Byeoung Kim
Eerdere bekende functies van Brian Byeoung Kim
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELLTRION, INC. | Corporate Officer/Principal | 01-06-2011 | 30-04-2012 |
| CELLTRION PHARM, INC. | Corporate Officer/Principal | 13-09-2011 | - |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Zuid-Korea | 4 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoraal
| Health Technology | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CELLTRION, INC. | Health Technology |
| CELLTRION PHARM, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
BIOHAUS Co., Ltd.
BIOHAUS Co., Ltd. Pharmaceuticals: MajorHealth Technology BIOHAUS Co., Ltd. engages in the development and manufacture of fucntional health and synthetic biology products. Its products include bio plastics and pulps and natural antibacterial wet tissues. The company was founded in August 2012 and is headquartered in Seongnam, South Korea. | Health Technology |
- Beurs
- Insiders
- Brian Byeoung Kim
- Ervaring
